Myriam Borgatta

Dr. Myriam Borgatta

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2024 in Toxics
Verified
Journal Article
Open access
PDF file
MBMyriam Borgatta
Myriam Borgatta
FBFlorian Breider
Florian Breider
Humans are chronically exposed to airborne microplastics (MPs) by inhalation. Various types of polymer particles have been detected in lung samples, which could pose a threat to human health. Inhalation toxicological studies are crucial for assessing the effects of airborne MPs and for exposure-reduction measures. This communication paper addresses important health concerns related to MPs, taking into consideration three levels of complexity, i.e., the particles themselves, the additives present in the plastics, and the exogenous substances adsorbed onto them. This approach aims to obtain a comprehensive toxicological profile of deposited MPs in the lungs, encompassing local and systemic effects. The physicochemical characteristics of MPs may play a pivotal role in lung toxicity. Although evidence suggests toxic effects of MPs in animal and cell models, no established causal link with pulmonary or systemic diseases in humans has been established. The transfer of MPs and associated chemicals from the lungs into the bloodstream and/or pulmonary circulation remains to be confirmed in humans. Understanding the toxicity of MPs requires a multidisciplinary investigation using a One Health approach.

1 March 2016 in Science of The Total Environment
Verified
Journal Article
Closed access
MBMyriam Borgatta
Myriam Borgatta
PWPatrice Waridel
Patrice Waridel
LDLaurent Arthur Decosterd
Laurent Arthur Decosterd
TBThierry Buclin
Thierry Buclin
NCNathalie Chèvre
Nathalie Chèvre

1 July 2015 in Science of The Total Environment
Verified
Journal Article
Closed access
MBMyriam Borgatta
Myriam Borgatta
LDLaurent Arthur Decosterd
Laurent Arthur Decosterd
PWPatrice Waridel
Patrice Waridel
TBThierry Buclin
Thierry Buclin
NCNathalie Chèvre
Nathalie Chèvre

14 June 2024 in Toxicology Letters
Verified
Journal Article
Open access
NHNancy B. Hopf
Nancy B. Hopf
HPHélène Paschoud
Hélène Paschoud
MBMyriam Borgatta
Myriam Borgatta
Holger KochHolger Koch
Holger Koch
CPClaudia Pälmke
Claudia Pälmke
ERElena Reale
Elena Reale
Population studies reveal widespread exposure to phthalates. Understanding their absorption, distribution, metabolism, and excretion is vital to reduce exposure. However, data on skin absorption remain limited. We thus aim to characterize the skin permeation of three phthalates in a mixture, neat or in emulsion; di(2-ethylhexyl) phthalate (d4-DEHP), dibutyl phthalate (d4-DBP), and diethyl phthalate (d4-DEP), by comparing in vitro human skin (800µm) permeation (24hours) results using flow-through diffusion cells with urine results obtained from volunteers exposed to the same mixture applied to a forearm (40 cm2). Metabolites were analyzed in receptor fluids and urine. Phthalates crossed the skin barrier and metabolized into monoesters before elimination. Increased permeation was observed for phthalates in emulsion compared to neat substances, with polyethylene glycol (PEG) in the receptor fluid enhancing emulsion permeation, but not affecting neat substances. In vitro results mirrored in vivo findings: DEP showed rapid permeation (J: ~2 ug/cm2/h) and urinary excretion peaking at six hours post-application, whereas DBP exhibited slower kinetics (J: ~0.1 ug/cm2/h), with a urinary peak at 15-17hours post-application. DEHP had minimal permeation (J: ~0.0002 ug/cm2/h) with no observable urinary peak. These findings underscore the importance of comprehending phthalate skin absorption for effective exposure mitigation strategies.

13 November 2014 in Journal of Proteome Research
Verified
Journal Article
Closed access
MBMyriam Borgatta
Myriam Borgatta
CHCéline Hernandez
Céline Hernandez
LDLaurent Arthur Decosterd
Laurent Arthur Decosterd
NCNathalie Chèvre
Nathalie Chèvre
PWPatrice Waridel
Patrice Waridel

1 April 2022 in Science of The Total Environment
Verified
Journal Article
Open access
MBMyriam Borgatta
Myriam Borgatta
PWPascal Wild
Pascal Wild
NHNancy B. Hopf
Nancy B. Hopf
Glycol ethers are organic solvents present in countless products for professional and domestic use. The main toxicological concerns are hematotoxicity, respiratory and reproductive toxicity. The general population can be exposed when using products containing one or several glycol ethers that evaporate or if sprayed, generate aerosols that can be inhaled. The rate at which glycol ethers enters blood following inhalation exposure are unknown in humans, and chemical risk assessors only rely on animal and in vitro toxicity studies. Propylene glycol monomethyl ether (PGME) and propylene glycol monobutyl ether (PGBE) are two examples of glycol ethers used worldwide. Our study aimed to provide human toxicokinetic data after inhalation exposure of low PGME and PGBE concentrations tested alone or in mixture. Healthy participants (n = 28) were exposed to 35 ppm (131 mg/m3) of PGME and 15 ppm (i.e., 83 mg/m3) of PGBE for 2 or 6 h. Blood was regularly collected during the exposure sessions. PGME and PGBE were immediately bioavailable in blood during exposure, and the mean absorption rates were up to 13 μg/L/min and 2.45 μg/L/min, respectively. Maximum mean blood concentration (Cmax) was 2.91 mg/L and 0.41 mg/L for PGME and PGBE. The cumulative internal doses over time (area under the curve, AUC) were 11 mg∗h/L and 1.81 mg∗h/L for PGME and PGBE. PGME and PGBE total blood uptake could possibly be higher in physically active individuals, such as workers. We recommend that glycol ethers present on the market undergo toxicological testing with the internal doses we found in our toxicokinetic study.